Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2021-04-27 2021-04-27
Drug Identification Number 01966219 01966219
Brand name THEOLAIR THEOLAIR
Common or Proper name Theophylline solution Theophylline solution
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients THEOPHYLLINE THEOPHYLLINE
Strength(s) 80MG 80MG
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 500 mL 500 mL
ATC code R03DA R03DA
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-04-26 2021-04-26
Remaining supply date 2019-11-30 2019-11-30
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments